The Vanguard Group - 23-1945930 13D and 13G filings for Kura Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:08 pm Purchase | 2023-12-29 | 13G | Kura Oncology, Inc. KURA | The Vanguard Group - 23-1945930 | 4,037,691 5.440% | 632,522 (+18.58%) | Filing |
| 2023-02-09 11:25 am Purchase | 2022-12-30 | 13G | Kura Oncology, Inc. KURA | The Vanguard Group - 23-1945930 | 3,405,169 5.090% | 3,405,169 (New Position) | Filing |